Columbia Seligman Premium Technology Growth Fund Inc Stock News

BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth-quarter distribution, pursuant to its managed distribution policy, in the amount of $0.4625 per share, which is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00 offering price in the Fund's initial public offering in November 2009. The fourth-quart...

Columbia Seligman Premium Technology Growth Fund offers a balance between growth and income, leveraging an option strategy to generate a 6.5% dividend yield. STK's diverse tech holdings focus on downside volatility mitigation, with semiconductors and software sectors comprising nearly half of its portfolio. Despite potential vulnerabilities, STK's price trading at a discount to NAV and consiste...

Closed-end funds (CEFs), with an average yield of around 8%, are terrific for just about any investor—especially those looking to their portfolios to help pay the bills.

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper draw-downs than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs w...

Hedge funds have a big problem: They can't beat the market anymore.

MINNEAPOLIS--(BUSINESS WIRE)--Columbia Seligman Premium Technology Growth Fund, Inc. (the “Fund”) (NYSE: STK) today held its 14th Annual Meeting of Stockholders (the “Meeting”) in Minneapolis, Minnesota. Stockholders voted in favor of the recommendations of the Fund's Board of Directors (the “Board”) on each of two proposals at the Meeting. Specifically, Stockholders re-elected Directors Kathle...

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology and immunology, today announced completion of enrollment for two clinical trials evaluating its ropeginterferon...

Columbia Seligman Premium Technology Growth Fund focuses on leading tech stocks with strong returns since inception. Top holdings include Lam Research, Broadcom, and Microsoft, all potentially overbought and due for a pullback. Nvidia's massive rally could spark a tech stock selloff, making it a good time to sell and wait for a pullback.